Regarding hematologic malignancies, abnormalities of AP-1 components exist in AML (9), chronic myelogenous leukemia (CML) (10), Hodgkin's disease (HD) (11), as well as anaplastic large cell lymphoma (ALCL) (12). This evidence concerns the gene JUN and chronic myelogenous leukemia, BCR-ABL1 positive.